Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection

BM Kaufman, PL Summers, DR Dubois… - Am J Trop Med …, 1989 - apps.dtic.mil
BM Kaufman, PL Summers, DR Dubois, WH Cohen, MK Gentry, RL Timchak, DS Burke
Am J Trop Med Hyg, 1989apps.dtic.mil
Five murine monoclonal antibodies Mabs reactive against the prM glyco-proteins of DEN-3
and-4 were used to passively protect mice in vivo against lethal challenge with homologous
and heterologous dengue virus serotypes. Four of the 5 prM-reactive monoclonals cross-
protected mice against heterologous challenge, whereas 1 protected against challenge with
only the homologous serotype. Although in vitro binding to virions was readily demonstrated,
only 2 of the prM Mabs had detectable neutralizing activity. The neutralizing activity could …
Abstract
Five murine monoclonal antibodies Mabs reactive against the prM glyco-proteins of DEN-3 and-4 were used to passively protect mice in vivo against lethal challenge with homologous and heterologous dengue virus serotypes. Four of the 5 prM-reactive monoclonals cross-protected mice against heterologous challenge, whereas 1 protected against challenge with only the homologous serotype. Although in vitro binding to virions was readily demonstrated, only 2 of the prM Mabs had detectable neutralizing activity. The neutralizing activity could not be enhanced by anti-mouse immunoglobulin or complement. However, 4 of the 5 prM Mabs fixed complement. This is the first report of prM-specific Mabs that are protective in mice.
apps.dtic.mil